Dr Michalis Papadakis
CEO & Co-Founder, Brainomix
Dr Michalis Papadakis is a driven entrepreneur with a vision to deliver innovative healthcare technologies that transform patient treatment. He is the co-founder and CEO of Brainomix, an award-winning, University of Oxford spin-out, specialising in AI-powered imaging software for precision medicine, particularly in stroke and lung fibrosis. Dr Papadakis has raised more than £30 million of investment building the company from the ground up, leading its global expansion in more than 30 countries in over 300 hospitals. Previously, he was the Scientific Director of the preclinical stroke lab at the University of Oxford, and he has a PhD in neurosciences from UCL School of Pharmacy. Dr Papadakis has been an invited speaker at international innovation conferences.